BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24992719)

  • 1. Measles and mumps outbreaks in the United States: Think globally, vaccinate locally.
    Whitaker JA; Poland GA
    Vaccine; 2014 Aug; 32(37):4703-4. PubMed ID: 24992719
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility to measles, mumps, and rubella in newly hired (2006-2008) healthcare workers born before 1957.
    Weber DJ; Consoli S; Sickbert-Bennett E; Miller MB; Rutala WA
    Infect Control Hosp Epidemiol; 2010 Jun; 31(6):655-7. PubMed ID: 20426576
    [No Abstract]   [Full Text] [Related]  

  • 4. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.
    Hyle EP; Rao SR; Jentes ES; Parker Fiebelkorn A; Hagmann SHF; Taylor Walker A; Walensky RP; Ryan ET; LaRocque RC
    Ann Intern Med; 2017 Jul; 167(2):77-84. PubMed ID: 28505632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mumps in the Vaccination Age: Global Epidemiology and the Situation in Germany.
    Beleni AI; Borgmann S
    Int J Environ Res Public Health; 2018 Jul; 15(8):. PubMed ID: 30065192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles and mumps outbreaks in Lebanon: trends and links.
    El Zarif T; Kassir MF; Bizri N; Kassir G; Musharrafieh U; Bizri AR
    BMC Infect Dis; 2020 Mar; 20(1):244. PubMed ID: 32216754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing Measles, Mumps, and Rubella in the Emergency Department.
    Gadler T; Martinez N; Ogg-Gress J
    Adv Emerg Nurs J; 2018; 40(2):110-118. PubMed ID: 29715253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles and human movement in Europe.
    Massad E
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30312454
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-preventable diseases on college campuses: the emergence of mumps.
    Williams WW; Sosin DM; Kaplan KM; Hersh BS; Preblud SR
    J Am Coll Health; 1989 Mar; 37(5):197-203. PubMed ID: 2703603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resurgence of measles and mumps: not just a childhood problem.
    Nageswaran P; Jenner L; Paul SP
    Br J Nurs; 2017 Apr; 26(8):471. PubMed ID: 28453330
    [No Abstract]   [Full Text] [Related]  

  • 16. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Immunization Week 2008--time for reflection.
    Kreidl P; Gomes H; Lopalco PL; Hagmaier K; Pastore Celentano L; Vasconcelos P; Yilmaz C
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768124
    [No Abstract]   [Full Text] [Related]  

  • 18. Live (vaccines) from New York.
    Forlenza CJ; Small TN
    Bone Marrow Transplant; 2013 Jun; 48(6):749-54. PubMed ID: 22890288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization].
    Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E
    Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis, treatment and prevention of measles].
    Lacroix L; Delaporte E; Siegrist CA; Sudre P; Wyler CA; Gervaix A
    Rev Med Suisse; 2008 Apr; 4(152):920-4. PubMed ID: 18578433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.